Herman Goossens

University of Antwerp — Belgium

Medicine · Health Sciences

69h-index36.2kcitations407works8.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pneumonia and Respiratory Infections(64), Antibiotic Use and Resistance(62), Antibiotic Resistance in Bacteria(59), Bacterial Identification and Susceptibility Testing(45), Antimicrobial Resistance in Staphylococcus(40)

Publications407 total

Molecular endotyping in people with bronchiectasis based on response to antibiotic treatment: iBEST study
ERJ Open Research·2025Open Access
Impact of co-infection with SARS-CoV-2 and other respiratory viruses on illness: Pooled analyses of 11 COVID-19 cohorts
Journal of Infection·2025· 2 citedOpen Access
Back to the future? Drastic drop in serotype 19A carriage in daycare centers within two years after a second switch to PCV13 in Belgium
Human Vaccines & Immunotherapeutics·2025· 2 citedOpen Access
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study
The Lancet Infectious Diseases·2025· 6 citedOpen Access
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study
The Lancet Infectious Diseases·2025· 7 citedOpen Access
Tracing carriage, acquisition, and transmission of ESBL-producing Escherichia coli over two years in a tertiary care hospital
Genome Medicine·2024· 4 citedOpen Access
Bridging immunotypes and enterotypes using a systems immunology approach
2024· 4 citedOpen Access
A longitudinal point prevalence survey of antimicrobial use and resistance in tertiary care hospitals in Kerman: results from the national Iranian multicenter point prevalence survey of antimicrobials in 2021
BMC Infectious Diseases·2024Open Access
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
The Lancet Infectious Diseases·2024· 75 cited
Association of <i>Staphylococcus aureus</i> Bacterial Load and Colonization Sites With the Risk of Postoperative <i>S. aureus</i> Infection
Open Forum Infectious Diseases·2024· 6 citedOpen Access
Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper
Infection·2024· 2 citedOpen Access
A microbiological and genomic perspective of globally collected <i>Escherichia coli</i> from adults hospitalized with invasive <i>E. coli</i> disease
Journal of Antimicrobial Chemotherapy·2024· 12 citedOpen Access
Did aetiology matter in illness duration and complications in patients presenting in primary care with acute respiratory tract infections early in the COVID-19 pandemic: An observational study in nine countries
European Journal of General Practice·2024Open Access
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
International Journal of Infectious Diseases·2024· 1 citedOpen Access
Epidemiology and genetic diversity of linezolid-resistant Enterococcus clinical isolates in Belgium from 2013 to 2021
Journal of Global Antimicrobial Resistance·2024· 11 citedOpen Access
High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland
BMC Microbiology·2024· 7 citedOpen Access
Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre
Virology Journal·2024· 1 citedOpen Access
Global-PPS targets for antimicrobial stewardship in paediatric patients at hospitals in Sanandaj, Western Iran, compared with Southeast Asian and European hospitals
Journal of Global Antimicrobial Resistance·2024· 4 citedOpen Access
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study
Infection·2024· 6 citedOpen Access
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)
Clinical Microbiology and Infection·2024· 35 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Zwi Berneman(6), Surbhi Malhotra‐Kumar(5), Carl Vael(5), Viggo Van Tendeloo(5), David L. Paterson(4), Wen‐Chien Ko(4), Anne von Gottberg(4), Kristine Desager(4), Evelien Smits(4), Samuel Coenen(4), Stephan Harbarth(3), Dominique L. Monnet(3), Waleria Hryniewicz(3), Mike Sharland(3), Margareta Ieven(3), José María Casellas(3), Lütfiye Mülazımoğlu(3), Gordon M. Trenholme(3), Keith P. Klugman(3), J. G. McCormack(3)